WATERLOO, Ontario & CULVER CITY, Calif.--(BUSINESS WIRE)--BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader in mobile communications, and NantHealth, a cloud-based information technology provider combining science and big data to transform healthcare, today announced the first secure clinical genome browser that gives doctors unprecedented access to patients’ genetic data on the BlackBerry® Passport smartphone – the NantOmics Cancer Genome Browser™. The NantOmics Cancer Genome Browser